
About Asons Pharmaceuticals Private Limited
Data last updated:
Asons Pharmaceuticals Private Limited is a private limited company based in Kalol, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2021PTC125300. Its GSTIN is 24AAVCA7228A1ZR (Gujarat).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Devangiben Jigneshkumar Shah and Jigneshkumar Ashvinbhai Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L.S No – 840/1 840/2 & 840/4, Village – Bedhiya Taluka – Kalol District – Panchmahal, Gujarat, India – 389310.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.4 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹8.35 Cr (net margin 25.8%) and EBITDA of ₹13.37 Cr (EBITDA margin 41.3%). Revenue has grown at a compounded annual rate (CAGR) of 158% over three years.
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹107.17 Cr on record. The company has 1 deal on record (1 rights issue); the latest was in November 2022. Its 6 peer companies in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Orichem Drugs & Pharmaceuticals Pvt. Ltd. with revenue of ₹33.03 Cr.
Asons Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0036694). For more details, the company can be reached via its website asonspharma.com.
Company details
Recognitions & Rankings of Asons Pharmaceuticals
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-24-0036694
Contact details
Asons Pharmaceuticals Private Limited's registered office is in Kalol, Gujarat. Its website is asonspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressL.S No – 840/1 840/2 & 840/4, Village – Bedhiya Taluka – Kalol District – Panchmahal, Gujarat, India – 389310
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Asons Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Asons Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Asons Pharmaceuticals Private Limited, buy the company report.
Financials of Asons Pharmaceuticals Private Limited
FY 2025 filings availableAsons Pharmaceuticals Private Limited reported revenue of ₹32.4 Cr (up 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 158% over three years, including 43% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹13.37 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹8.35 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 41.3% | |||
| Net Profit Margin | 25.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Asons Pharmaceuticals Private Limited, buy the company report.
Board of directors of Asons Pharmaceuticals Private Limited
Asons Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devangiben Jigneshkumar Shah Also directs: Purecaps India Private Limited, Asons Biotech Private Limited | Director | 02 Sep 2021 | 5 Years 2 Months | Current |
| Jigneshkumar Ashvinbhai Shah Also directs: Purecaps India Private Limited, Asons Biotech Private Limited | Director | 02 Sep 2021 | 5 Years 2 Months | Current |
| Kiran Mohanlal Jain Also directs: Shilpa Polypack Private Limited | Director | 20 Feb 2025 | 1 Years 9 Months | Current |
| Uttamkumar Mohanlal Jain Also directs: Shilpa Polypack Private Limited | Director | 20 Feb 2025 | 1 Years 9 Months | Current |
Peer comparison
Asons Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orichem Drugs & Pharmaceuticals Pvt. Ltd. | ₹33.03 Cr (FY 2025) | 21.0% | Indore, Madhya Pradesh, India | |||
| Maheshwari Pharmaceuticals (India) Limited | ₹32.92 Cr (FY 2024) | 9.0% | Delhi, India | |||
| Asolution Pharmaceuticals Private Limited | ₹32.73 Cr (FY 2024) | 11.0% | Mumbai, Maharashtra, India | |||
| Asons Pharmaceuticals Private Limitedthis company | ₹32.4 Cr (FY 2025) | ₹8.35 Cr | 25.8% | 43.0% | 10 | Kalol, Gujarat, India |
| Torrvis Pharmaceuticals Private Limited | ₹31.91 Cr (FY 2025) | 12.0% | Delhi, India | |||
| R P L (India) Pharmaceuticals Private Limited | ₹31.91 Cr (FY 2025) | 13.0% | New Delhi, Delhi, India | |||
| Emcee Pharmaceuticals Pvt Ltd | ₹31.02 Cr (FY 2025) | 14.0% | Kalyani, West Bengal, India |
To see the full peer comparison of Asons Pharmaceuticals Private Limited, buy the company report.
Auditor
Asons Pharmaceuticals Private Limited is audited by AIMS & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AIMS & ASSOCIATES | FY 2023 | 127628W |
Shareholding
The shareholding of Asons Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Asons Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2025 | 101116628 | Others | ₹19 Cr | Open | |
| 27 Jun 2025 | 101117705 | Others | ₹49.75 Cr | Open | |
| 15 Mar 2022 | 100551183 | Others | ₹17.29 Cr | Open | |
| 31 Dec 2021 | 100551173 | Others | ₹21.13 Cr | Open |
To see the full charge records of Asons Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Asons Pharmaceuticals Private Limited has 1 deal on record (1 rights issue); the latest was in November 2022.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2022 | Rights issue | ₹2.99 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Asons Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Asons Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Asons Pharmaceuticals Private Limited has a workforce of 10 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 10 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Asons Pharmaceuticals Private Limited, buy the company report.
GST
Asons Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAVCA7228A1ZR | Gujarat | Active | 16 Sep 2021 |
To see the full GST registrations and return filing status of Asons Pharmaceuticals Private Limited, buy the company report.
Recent activity
Asons Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Kiran Mohanlal Jain was appointed as Director on 20 Feb 2025.
1 earlier event is in the company report.
Frequently asked questions
Asons Pharmaceuticals is an active private limited company based in Kalol, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 September 2021 (5+ years old) and is registered under CIN U24304GJ2021PTC125300.
Asons Pharmaceuticals has 4 current directors:
- Devangiben Jigneshkumar Shah - Director
- Jigneshkumar Ashvinbhai Shah - Director
- Kiran Mohanlal Jain - Director
- Uttamkumar Mohanlal Jain - Director
The latest financial statements of Asons Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Asons Pharmaceuticals is 24AAVCA7228A1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Asons Pharmaceuticals is U24304GJ2021PTC125300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Asons Pharmaceuticals was incorporated on 02 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Asons Pharmaceuticals has 1 deal on record (1 rights issue); the latest was in November 2022.
The peers of Asons Pharmaceuticals by revenue are Orichem Drugs & Pharmaceuticals Pvt. Ltd, Maheshwari Pharmaceuticals (India) Limited, Asolution Pharmaceuticals Private Limited, Torrvis Pharmaceuticals Private Limited, R P L (India) Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kiran Mohanlal Jain was appointed as Director on 20 Feb 2025. Uttamkumar Mohanlal Jain was appointed as Director on 20 Feb 2025. Devangiben Jigneshkumar Shah was appointed as Director on 02 Sep 2021. Asons Pharmaceuticals has 4 board changes on record in total.
Yes, Asons Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Asons Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0036694).

